Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07117136) titled 'Blinatumomab Consolidation in Real World' on Aug. 5.
Study Type: Observational
Primary Sponsor: Medical College of Wisconsin
Condition:
B-Cell Acute Lymphoblastic Leukaemia
Recruitment Status: Not recruiting
Date of First Enrollment: September 1, 2025
Target Sample Size: 200
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07117136
Published by HT Digital Content Services with permission from Health Daily Digest....